Please assess the completion status of the following clinical trial:

Trial Title: Preoperative Methylprednisolone in Endovascular Aortic Repair

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Elective endovascular repair of an asymptomatic abdominal aortic aneurysm.~* Informed signed consent~Exclusion Criteria:~* Positive HIV status, positive hepatitis B or C status~* Immunoinflammatory disease - except topically treated skin disease and respiratory disease.~* Glaucoma~* Gastric or duodenal ulcer~* Systemic fungal infection~* Immunosuppressive treatment~* Current treatment for cancer~* Allergy towards contents of Solu-Medrol~* Alcohol consumption: Men \> 21 drinks and women \> 14 drinks weekly~* Pregnancy~* Lack of informed signed consent~* Patients where follow up is planned at other location than Rigshospitalet.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Methylprednisolone (Type: ACTIVE_COMPARATOR): 75 patients will receive a single preoperative dosage of Methylprednisolone
- Physiological Saline (Type: PLACEBO_COMPARATOR): 75 patients will receive a single preoperative dosage of Physiological Saline

Based on this trial design, predict the completion outcome and termination type (if applicable).